Abstract:Obesity – an established, modifiable risk factor for pancreatic ductal adenocarcinoma (PDAC) – has increased in prevalence worldwide yet the precise mechanisms underlying its propensity to promote cancer have remained an enigma. Alterations to the gut microbiota, the microorganisms that colonize the intestinal tract of humans and mice, may provide a link between obesity and PDAC, offering a previously untapped target to develop novel anti-cancer strategies in this highly lethal disease. To ascertain the importance of the obesity-associated microbiome in PDAC progression, we leveraged our previously established autochthonous model of obesity-associated PDAC (Pdx1-Cre; KrasLSL-G12D/+; LepOb/Ob) (KCO) which allows for rapid and reversible weight gain in a Kras-driven mouse tumor model that closely mimics the genetic and histologic features of human PDAC progression. Ablation of the gut microbiome via broad-spectrum antibiotics intercepted tumor development in KCO mice highlighting the importance of the gut microbiome in obesity-driven PDAC. By correlating microbial composition to tumor burden in antibiotic-treated and control mice via 16S rRNA sequencing, we are identifying microbial communities that may be causal for tumor development. In parallel studies, we performed 16S rRNA sequencing on feces serially collected from wild-type, LepOb/Ob ad libitum-fed mice (AL), and LepOb/Ob mice on calorie restriction (CR), which induces rapid weight loss. We found that obesity causes reversible changes to gut microbial composition including an increase in Proteobacteria, a phylum that holds the most known species to secrete histamine, a bioamine implicated in pancreatitis, a PDAC risk factor, and PDAC development itself. Concordant with these findings, Parallel Receptorome Expression and Screening via Transcriptional Output-SALSA (PRESTO-SALSA), a novel high-throughput system that allows for sensitive detection of microbial metabolites that exhibit mammalian GPCR agonism, feces from LepOb/Ob AL mice showed robust activation of histamine receptors (HRHs), while feces from obese mice subject to CR exhibited reduced Proteobacteria species and decreased capacity to activate mammalian HRHs, suggesting weight loss by CR mitigates microbe-derived histamine. Ongoing studies are testing whether microbe-derived histamine is necessary and sufficient for the tumor-promoting effects of obesity. Collectively, our results establish a dependency for the gut microbiome in obesity-driven PDAC, identify reversible obesity-induced microbial communities in the gut, and nominate microbial metabolites capable of activating pro-tumorigenic GPCR pathways as potential causative mechanisms. Citation Format: Christian F. Ruiz, Rylee McDonnell, Lauren Lawres, Yiyun Cao, Deguange Song, Nicole Sonnert, Noah Palm, Mandar D. Muzumdar. Obesity transforms the gut microbiome to invoke a cancer permissive state [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr C048.

Obesity induces phenotypic switching of gastric smooth muscle cells through the activation of the PPARD/PDK4/ANGPTL4 pathway

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

New mechanistic insights of anti-obesity by sleeve gastrectomy-altered gut microbiota and lipid metabolism

Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity

Deficiency of GPR10 and NPFFR2 receptors leads to sex-specific prediabetic syndrome and late-onset obesity in mice

Intestinal epigenomic alterations are associated with a dysregulated nutrient absorption phenotype in obesity

Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity

Macrophages and Mast Cells in the Gastric Mucosa of Patients with Obesity Undergoing Sleeve Gastrectomy

Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake

Obesity Phenotypes Are Preserved in Intestinal Stem Cell Enteroids from Morbidly Obese Patients

An Association between Decreased Small Intestinal RNA Modification and Disturbed Glucagon-like Peptide-1 Secretion under High-Fat Diet Stress

Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects who are Overweight or have Obesity

Obesity accelerates endothelial-to-mesenchymal transition in adipose tissues of mice and humans

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

Understanding the gastrointestinal tract in obesity: From gut motility patterns to enzyme secretion

Abstract C048: Obesity transforms the gut microbiome to invoke a cancer permissive state

Obesity-Facilitated Colon Cancer Progression Is Mediated by Increased Diacylglycerol O-Acyltransferases 1 and 2 Levels

Comparison of Esophageal Dysmotility and Reflux Burden in Patients with Different Metabolic Obesity Phenotypes Based on High-Resolution Impedance Manometry and 24-h Impedance-pH

Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity

Metabolic and Gut Microbial Characterization of Obesity-Prone Mice under a High-Fat Diet